WO1994009838A1 - Apparatus for removal of pleural effusion fluid - Google Patents
Apparatus for removal of pleural effusion fluid Download PDFInfo
- Publication number
- WO1994009838A1 WO1994009838A1 PCT/US1993/010530 US9310530W WO9409838A1 WO 1994009838 A1 WO1994009838 A1 WO 1994009838A1 US 9310530 W US9310530 W US 9310530W WO 9409838 A1 WO9409838 A1 WO 9409838A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fluid
- valve
- tube
- passageway
- catheter
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M39/0606—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof without means for adjusting the seal opening or pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/84—Drainage tubes; Aspiration tips
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/062—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof used with a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
- A61M2039/0646—Duckbill-valve
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M39/00—Tubes, tube connectors, tube couplings, valves, access sites or the like, specially adapted for medical use
- A61M39/02—Access sites
- A61M39/06—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof
- A61M2039/0633—Haemostasis valves, i.e. gaskets sealing around a needle, catheter or the like, closing on removal thereof the seal being a passive seal made of a resilient material with or without an opening
- A61M2039/066—Septum-like element
Definitions
- Pleural effusion refers to the effusion of fluid into the pleural space.
- the pleural space normally contains approximately 5 to 20 L of fluid.
- the pH, glucose and electrolytes of the fluid are • equilibrated with plasma, but the fluid is relatively protein-free.
- the fluid is the result of the hydrostatic-oncotic pressure of the capillaries of the parietal pleura.
- About 80-90% of the fluid is reabsorbed by the pulmonary venous capillaries of the visceral pleura, and the remaining 10-20% is reabsorbed by the pleural lymphatic system.
- the turnover of fluid in the pleural space is normally quite rapid - roughly 35 to 75% per hour, so that 5 to 10 liters of fluid move through the pleural space each day.
- a disruption in the balance between the movement of fluid into the pleural space and the movement of fluid out of the pleural space may produce excessive fluid accumulation in the pleural space.
- Such disruptions may include, for example, (1) increased capillary permeability resulting from inflammatory processes such as pneumonia, (2) increased hydrostatic pressure as in congestive heart failure, (3) increased negative intrapleural pressure as seen in atelectasis, (4) decreased oncotic pressure as occurs in the nephrotic syndrome with hypoalbuminemia, and (5) increased oncotic pressure of pleural fluid as occurs in the inflammation of pleural tumor growth or infection.
- Pleurectomy and pleural abrasion is generally effective in obliterating the pleural space and, thus, controlling the malignant pleural effusion. This procedure is done in many patients who undergo thoracotomy for an undiagnosed pleural effusion and are found to have malignancy, since this would prevent the subsequent development of a symptomatic pleural effusion.
- pleurectomy is a major surgical procedure associated with substantial morbidity and some mortality. Therefore, this procedure is usually reserved for patients with an expected survival of at least several months, who are in relative good condition, who have a trapped lung, or who have failed a sclerosing agent procedure.
- Another approach to removing fluid from the pleural space is to surgically implant a chest tube.
- Thoracentesis is a common approach to removing pleural fluid, in which a needled catheter is introduced into the pleural space through an incision in the chest cavity and fluid is positively drawn out through the catheter using a syringe or a vacuum source.
- the procedure may also include aspiration utilizing a separate syringe.
- the present invention is a device for draining pleural effusion fluids using a catheter that is implanted in the pleural space for extended periods of time.
- the proximal end of the catheter is fenestrated to receive the pleural fluid and the distal end is in communication with a vacuum source or negative pressure source to draw fluid from the pleural space into the catheter through the multiple orifices, and through the catheter toward the negative pressure source.
- a valve to close the catheter when the negative pressure source is not connected to the catheter between fluid removals, and to open the catheter when the negative pressure source is connected to the catheter for the removal of fluid.
- the valve is normally closed, so that fluid does not drain through the catheter and air does not enter the catheter when the negative pressure source is not connected to the catheter, but opens when the apparatus is configured for fluid removal, as upon connection of the negative pressure source.
- the valve is also designed such that a tube can be introduced into the valve to apply fluids therein, thereby allowing the introduction of materials into the pleural space if desired.
- the valve may be capped by a cap which may include an antimicrobial and/or antibacterial solution to avoid contamination.
- FIG. 3 is a partially sectional view of the valve of FIG. 2 , with a tube inserted therein to open the valve.
- FIG. 4 is a diagrammatic view of the apparatus of the present invention including a vacuum bottle to produce a negative pressure on the proximal end of the catheter.
- FIG. 5 is a diagrammatic view of the apparatus of the present invention including a syringe to introduce fluid into the catheter.
- FIG. 1 A pictorial view of a catheter 12 for use with the present invention is shown in FIG. 1.
- the catheter 12 in a preferred embodiment has a proximal end 14 and a distal end 16 may be about twenty-four inches long, the proximal ten inches being fenestrated with a series of holes 18 allowing fluid communication between the exterior of the catheter and the lumen.
- the catheter is made of a flexible material such as silicone rubber. A few inches distal from the holes 18 may be a Dacron cuff 19.
- the catheter is implanted into the pleural space using procedures known in the art. For example, one technique is to make an incision between adjacent ribs of the patient's rib cage in a direction superiorly and posteriorly toward the pleural space.
- the pleural space is aspirated using a needle and then a J-wire is inserted through the needle and into the pleural space and the needle is removed.
- a sheath and dilator are threaded over the J-wire and into the pleural space and the J-wire is removed.
- the dilator is removed from within the sheath.
- the catheter is then threaded through the sheath and into the pleural space and the sheath is removed.
- the distal end 16 of the catheter 12 is attached to a valve 60.
- the valve 60 is shown in detail in FIG. 2.
- the valve includes a body 62 having a distal portion 64 and a proximal portion 65 which are attached to one another by an adhesive or other suitable means.
- the end 66 of the distal portion 64 and the end 69 of the proximal portion 65 each have a hole, and the centers of those portions 64 and 65 are hollowed out, thereby forming a passageway 68 through the valve body 62.
- a "duckbill" valve 72 Positioned within this passageway 68 is a "duckbill" valve 72 which is of the type known in the art consisting of an elastomeric, molded, one-piece dome containing a slit in the center of the domed portion.
- the duckbill valve 72 may be opened by inserting an elongated member through the passageway 68 from the distal portion 64 to pry apart the valve in the manner described below.
- the elastomeric seal 78 is a disk-shaped element having a hole 79 through the center to seal against the outside of the drainage tube 110 or introduction tube 150 in the manner described below.
- the other end of the drainage tube 110 may be in communication with a vacuum bottle 114 or any other negative pressure source such as a mechanical device to draw fluid from the pleural space, into the catheter, through the catheter and the valve, through the drainage tube and into a fluid collection reservoir or the vacuum bottle.
- a vacuum bottle 114 or any other negative pressure source such as a mechanical device to draw fluid from the pleural space, into the catheter, through the catheter and the valve, through the drainage tube and into a fluid collection reservoir or the vacuum bottle.
- the fluid removal procedure is discontinued by simply withdrawing the drainage tube 110 from the valve 60. As the end of the drainage tube comes out of the duckbill valve 72, the valve closes and prevents further fluid from flowing out of the valve and also prevents air from entering the catheter and possibly flowing into the pleural space.
- a similar procedure can be used to introduce material into the pleural space as shown in FIG. 5, using the same implanted catheter 12 and attached valve 60. Rather than utilizing a drainage tube 110, an introduction tube 150 of the same configuration is used. One end of the introduction tube is attached to a syringe 152 (or infusion pump or other known device for introducing fluid into the body) and the other end is inserted into the valve 60.
- the end of the introduction tube 150 goes through and seals against the hole 79 of the elastomeric seal 78, and then opens and goes through the duckbill valve 72 to access the catheter lumen.
- leak-proof communication is established from the syringe interio.r to the pleural space.
- the distal end 64 of the valve 60 may be capped with a cap 140 as shown in FIG. 6 when fluid is not being removed from or introduced to the pleural space.
- the cap 140 is not necessary to close the valve, since the valve is already closed by the duckbill valve 72 in the passageway 68 when there is no drainage tube or introduction tube.
- the cap 140 may have a threaded sleeve 142 to mate with threads on the valve 60.
- the cap 140 may be of the sterilant-filled type in which the cap is stored in a chamber with mating threads which is filled with a sterilant such as iodine when the cap is not in use.
Abstract
An apparatus and method for establishing fluid communication with a pleural space, including a catheter (12) attached to a valve (60) that is normally closed but openable by the insertion of a tube in the side opposite the catheter (12). The catheter (12) is implanted into the pleural space and is accessed by inserting a tube into the valve on the side opposite the catheter to add or remove fluid to and from the pleural space using a negative pressure source.
Description
-- Apparatus for Removal of Pleural Effusion Fluid --
FIELD OF THE INVENTION
The present invention relates to the field of removing pleural effusion fluids and, in particular, to a method and apparatus for long-term implantation into the pleural space for continuous removal of pleural fluid.
BACKGROUND OF THE INVENTION
Pleural effusion refers to the effusion of fluid into the pleural space. The pleural space normally contains approximately 5 to 20 L of fluid. The pH, glucose and electrolytes of the fluid are • equilibrated with plasma, but the fluid is relatively protein-free. The fluid is the result of the hydrostatic-oncotic pressure of the capillaries of the parietal pleura. About 80-90% of the fluid is reabsorbed by the pulmonary venous capillaries of the visceral pleura, and the remaining 10-20% is reabsorbed by the pleural lymphatic system. The turnover of fluid in the pleural space is normally quite rapid - roughly 35 to 75% per hour, so that 5 to 10 liters of fluid move through the pleural space each day.
A disruption in the balance between the movement of fluid into the pleural space and the movement of fluid out of the pleural space may produce excessive fluid accumulation in the pleural space. Such disruptions may include, for example, (1) increased capillary permeability resulting from inflammatory processes such as pneumonia, (2) increased hydrostatic pressure as in congestive heart failure, (3) increased negative intrapleural pressure as seen in atelectasis, (4) decreased oncotic pressure as occurs in the nephrotic syndrome with hypoalbuminemia, and (5) increased oncotic pressure of pleural fluid as occurs in the inflammation of pleural tumor growth or infection. Pleural effusion is particularly common in
patients with disseminated breast cancer, lung cancer or lymphatic cancer and patients with congestive heart failure, but also occurs in patients with nearly all other forms of malignancy. The clinical manifestations of pleural effusion include dyspnea, cough and chest pain which diminish the patient's quality of life. Although pleural effusion typically occurs toward the end of terminal malignancies such as breast cancer, it occurs earlier in other diseases. Therefore relieving the clinical manifestations of pleural effusion is of a real and extended advantage to the patient. For example, non- breast cancer patients with pleural effusion have been known to survive for years. See "Pleural Effusion in Cancer Patients", Izbicki, et al.. Cancer October 1975, p. 1511.
There are a number of treatments for pleural effusion. If the patient is asymptomatic and the effusion is known to be malignant or paramalignant, treatment may not be required. Such patients may develop progressive pleural effusions that eventually do produce symptoms requiring treatment, but some will reach a stage where the effusions and reabsorption reach an equilibrium that is still asymptomatic and does not necessitate treatment.
Pleurectomy and pleural abrasion is generally effective in obliterating the pleural space and, thus, controlling the malignant pleural effusion. This procedure is done in many patients who undergo thoracotomy for an undiagnosed pleural effusion and are found to have malignancy, since this would prevent the subsequent development of a symptomatic pleural effusion. However, pleurectomy is a major surgical procedure associated with substantial morbidity and some mortality. Therefore, this procedure is usually reserved for patients with an expected survival of at
least several months, who are in relative good condition, who have a trapped lung, or who have failed a sclerosing agent procedure.
In general, systemic chemotherapy is disappointing for the control of malignant pleural effusions. However, patients with lymphoma, breast cancer, or small cell carcinoma of the lung may obtain an excellent response to chemotherapy.
Another approach to removing fluid from the pleural space is to surgically implant a chest tube.
Such tubes are commonly quite rigid and fairly large in diameter and are implanted by making a surgical incision and spreading apart adjacent ribs to fit the tube into place. Such procedures are painful to the patient, both initially when the chest tube is inserted and during the time it remains within the pleural space.
Thoracentesis is a common approach to removing pleural fluid, in which a needled catheter is introduced into the pleural space through an incision in the chest cavity and fluid is positively drawn out through the catheter using a syringe or a vacuum source. The procedure may also include aspiration utilizing a separate syringe. There are a number of difficulties in thoracentesis, including the risk of puncturing a lung with the catheter tip or with the needle used to introduce the catheter, the risk of collapsing a lung by relieving the negative pressure in the pleural space, the possibility of aggravating the pleural effusion by stimulating fluid production in the introduction of the catheter, and the risk of infection. One of the primary difficulties with ordinary thoracentesis procedures is that fluid reaccumulates in the pleural space relatively quickly after the procedure is performed, and so it is necessary to perform the procedure repeatedly - as
often as every few days. In fact, some studies found that the fluid re-accumulates in one to three days in most cases and re-accumulates within a month in 97% of the cases studied. See "Diagnosis and Treatment of Malignant Pleural Effusion", F.J. Hausheer, J. . Yarbro, Seminars in Oncology. March 1985, p. 54; "Malignant Effusion", Anderson, et al., Cancer, April 1974, p. 916. Of course, each time the procedure is repeated the risks identified above are heightened. Moreover, the comfort to the patient resulting from the procedure begins to offset by the discomfort of the procedure itself.
There is therefore a need for a method and apparatus for removing pleural effusion which does not require repeated invasion of the pleural space in a manner which produces repeated patient discomfort, infection risks, risks of accidental trauma to the lungs, and the potential for stimulating fluid production. Ideally, such a method and apparatus would be relatively simple in design and manufacture and would be within the capabilities of ordinary physicians to use.
SUMMARY OF THE INVENTION The present invention is a device for draining pleural effusion fluids using a catheter that is implanted in the pleural space for extended periods of time. The proximal end of the catheter is fenestrated to receive the pleural fluid and the distal end is in communication with a vacuum source or negative pressure source to draw fluid from the pleural space into the catheter through the multiple orifices, and through the catheter toward the negative pressure source.
Between the negative pressure source and the distal end of the catheter is a valve to close the catheter when the negative pressure source is not
connected to the catheter between fluid removals, and to open the catheter when the negative pressure source is connected to the catheter for the removal of fluid. The valve is normally closed, so that fluid does not drain through the catheter and air does not enter the catheter when the negative pressure source is not connected to the catheter, but opens when the apparatus is configured for fluid removal, as upon connection of the negative pressure source. The valve is also designed such that a tube can be introduced into the valve to apply fluids therein, thereby allowing the introduction of materials into the pleural space if desired. The valve may be capped by a cap which may include an antimicrobial and/or antibacterial solution to avoid contamination.
BRIEF DESCRIPTION OF THE DRAWINGS
FIG. 1 is a pictorial view of the catheter of the present invention prepared for implantation. FIG. 2 is a partially sectional view of the valve utilized in an embodiment of the invention.
FIG. 3 is a partially sectional view of the valve of FIG. 2 , with a tube inserted therein to open the valve. FIG. 4 is a diagrammatic view of the apparatus of the present invention including a vacuum bottle to produce a negative pressure on the proximal end of the catheter.
FIG. 5 is a diagrammatic view of the apparatus of the present invention including a syringe to introduce fluid into the catheter.
FIG. 6 is a partially sectional view of the valve utilized in an embodiment of the invention with a valve cap.
DETAILED DESCRIPTION OF THE INVENTION
A pictorial view of a catheter 12 for use with the present invention is shown in FIG. 1. The catheter 12 in a preferred embodiment has a proximal end 14 and a distal end 16 may be about twenty-four inches long, the proximal ten inches being fenestrated with a series of holes 18 allowing fluid communication between the exterior of the catheter and the lumen. The catheter is made of a flexible material such as silicone rubber. A few inches distal from the holes 18 may be a Dacron cuff 19.
The catheter is implanted into the pleural space using procedures known in the art. For example, one technique is to make an incision between adjacent ribs of the patient's rib cage in a direction superiorly and posteriorly toward the pleural space.
The pleural space is aspirated using a needle and then a J-wire is inserted through the needle and into the pleural space and the needle is removed. A sheath and dilator are threaded over the J-wire and into the pleural space and the J-wire is removed. The dilator is removed from within the sheath. The catheter is then threaded through the sheath and into the pleural space and the sheath is removed.
The distal end 16 of the catheter 12 is attached to a valve 60. The valve 60 is shown in detail in FIG. 2. As shown in FIG. 2, the valve includes a body 62 having a distal portion 64 and a proximal portion 65 which are attached to one another by an adhesive or other suitable means. The end 66 of the distal portion 64 and the end 69 of the proximal portion 65 each have a hole, and the centers of those portions 64 and 65 are hollowed out, thereby forming a passageway 68 through the valve body 62. Positioned within this passageway 68 is a "duckbill" valve 72 which is of the type known in the art consisting of an elastomeric, molded, one-piece dome containing a slit
in the center of the domed portion. The duckbill valve 72 may be opened by inserting an elongated member through the passageway 68 from the distal portion 64 to pry apart the valve in the manner described below. Adjacent to the duckbill valve 72 toward the distal portion 64 is an elastomeric seal 78. The elastomeric seal 78 is a disk-shaped element having a hole 79 through the center to seal against the outside of the drainage tube 110 or introduction tube 150 in the manner described below.
Fluid is withdrawn from the pleural space by inserting a drainage tube 110 into the distal portion 64 of the valve 60 as shown in FIGs. 3-4. The drainage tube is slightly larger in its outside diameter then the hole 79 in the elastomeric seal 78, thereby ensuring that a seal is created between the elastomeric seal 78 and the outside of the drainage tube to prevent fluid from leaking. The insertion of the drainage tube 110 into the valve 60 opens the duckbill valve 72 and thereby accesses the interior of the catheter 12. As shown in FIG. 4, the other end of the drainage tube 110 may be in communication with a vacuum bottle 114 or any other negative pressure source such as a mechanical device to draw fluid from the pleural space, into the catheter, through the catheter and the valve, through the drainage tube and into a fluid collection reservoir or the vacuum bottle.
The fluid removal procedure is discontinued by simply withdrawing the drainage tube 110 from the valve 60. As the end of the drainage tube comes out of the duckbill valve 72, the valve closes and prevents further fluid from flowing out of the valve and also prevents air from entering the catheter and possibly flowing into the pleural space. A similar procedure can be used to introduce material into the pleural space as shown in FIG. 5,
using the same implanted catheter 12 and attached valve 60. Rather than utilizing a drainage tube 110, an introduction tube 150 of the same configuration is used. One end of the introduction tube is attached to a syringe 152 (or infusion pump or other known device for introducing fluid into the body) and the other end is inserted into the valve 60. The end of the introduction tube 150, like the end of the drainage tube 110 previously described, goes through and seals against the hole 79 of the elastomeric seal 78, and then opens and goes through the duckbill valve 72 to access the catheter lumen. Thus, leak-proof communication is established from the syringe interio.r to the pleural space. The distal end 64 of the valve 60 may be capped with a cap 140 as shown in FIG. 6 when fluid is not being removed from or introduced to the pleural space. The cap 140 is not necessary to close the valve, since the valve is already closed by the duckbill valve 72 in the passageway 68 when there is no drainage tube or introduction tube. However, it may still be desirable to cap the valve to prevent contamination of the passageway 68 and to reduce the possibility of infection. The cap 140 may have a threaded sleeve 142 to mate with threads on the valve 60. To further reduce the possibility of infection, the cap 140 may be of the sterilant-filled type in which the cap is stored in a chamber with mating threads which is filled with a sterilant such as iodine when the cap is not in use.
Claims
1. A method for accessing the pleural space of a patient using a catheter with a distal end and a proximal end and a lumen therebetween, wherein the distal end is in fluid communication with a valve having a passageway with a proximal end attached to the distal end of the catheter and a distal end opposite the proximal end, the valve being normally closed unless a member is inserted into the passageway from the distal end toward the proximal end to open the valve, the method comprising inserting the catheter through the chest wall of the patient so that the proximal end of the catheter is in the pleural space; • and accessing the pleural space by inserting a tube into the distal end of the valve to open the valve passageway.
2. The method of claim 1, further comprising withdrawing fluid from the pleural space by establishing fluid communication between the distal end of the tube and a fluid collector so that fluid flows from the pleural space into the proximal end of the catheter, through the catheter lumen and into the passageway of the valve, through the passageway of the valve and into the cube and through the tube into the fluid collector.
3. The method of claim 2, wherein the fluid collector is at a negative pressure.
4. The method of claim 3, wherein the fluid collector is a vacuum bottle.
5. The method of claim 1, further comprising placing fluid into the pleural space by establishing fluid communication between the distal end of the tube and a fluid source so that fluid flows from the fluid source and into the tube, through the tube and into the passageway of the valve, through the passageway of the valve and into the lumen of the catheter, and through the lumen of the catheter and out the proximal end of the catheter into the pleural space.
6. The method of claim 5, wherein the fluid source is a syringe with a plunger and a barrel, and the fluid is forced from the syringe into the tube by pushing the plunger into the barrel.
7. The method of claim 1, wherein the valve includes a normally closed one-way valve allowing the passage of a member through the passageway from the distal end to the proximal end but does not normally allow the passage of fluid though the passageway from the proximal end to the distal end, the one-way valve extending into the passageway and deformable by said member to allow the member to pass therebetween.
8. The method of claim 7, wherein the valve includes an elastomeric seal to seal the valve to the member, the elastomeric seal being attached to the passageway and having a hole therethrough to receive the member.
9. An apparatus for establishing fluid communication between the pleural space of a patient and a tube outside the patient, comprising a catheter having a distal end, a proximal end and a lumen therebetween; and a valve having a proximal end attached to and in fluid communication with the distal end of the catheter, a proximal end opposite the distal end, and a passageway therebetween, the passageway being normally closed but openable by the insertion of the tube from the distal end toward the proximal end.
10. The apparatus of claim 9, wherein the valve includes a seal in the passageway to removably receive said tube so that fluid can pass between the passageway and the tube without leaking.
11. The apparatus of claim 10, wherein the valve includes an elastomeric valve positioned in the passageway to normally prevent passage from the proximal end to the distal end of the passageway, the elastomeric valve being deformable to receive the tube to allow fluid to pass between the passageway and the tube upon insertion of the tube in the passageway.
12. The apparatus of claim 11, wherein the elastomeric valve consists of a molded, one-pieced dome, containing a slit in the center of the dome deformably separable upon the insertion of a tube.
13. The apparatus of claim 9, further comprising said tube and a fluid collector in fluid communication with the tube to receive fluid from the tube.
14. The apparatus of claim 13, wherein the fluid collector is a negative pressure source.
15. The apparatus of claim 9, further comprising said tube and a fluid source in fluid communication with the tube.
16. The apparatus of claim 15, wherein the fluid source is a syringe.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU56656/94A AU5665694A (en) | 1992-11-04 | 1993-11-03 | Apparatus for removal of pleural effusion fluid |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US97172292A | 1992-11-04 | 1992-11-04 | |
US07/971,722 | 1992-11-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1994009838A1 true WO1994009838A1 (en) | 1994-05-11 |
Family
ID=25518719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1993/010530 WO1994009838A1 (en) | 1992-11-04 | 1993-11-03 | Apparatus for removal of pleural effusion fluid |
Country Status (3)
Country | Link |
---|---|
US (1) | US5484401A (en) |
AU (1) | AU5665694A (en) |
WO (1) | WO1994009838A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014152712A1 (en) * | 2013-03-15 | 2014-09-25 | Merit Medical Systems, Inc. | Lockable syringe assemblies and related devices and methods |
US11350945B2 (en) | 2017-11-13 | 2022-06-07 | Merit Medical Systems, Inc. | Staged deflation syringe systems and associated methods |
Families Citing this family (145)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8251986B2 (en) | 2000-08-17 | 2012-08-28 | Angiodynamics, Inc. | Method of destroying tissue cells by eletroporation |
US6994706B2 (en) | 2001-08-13 | 2006-02-07 | Minnesota Medical Physics, Llc | Apparatus and method for treatment of benign prostatic hyperplasia |
US6790237B2 (en) * | 2001-10-09 | 2004-09-14 | Scimed Life Systems, Inc. | Medical stent with a valve and related methods of manufacturing |
US6846292B2 (en) | 2002-02-19 | 2005-01-25 | Mohamed Bakry | Pleural biopsy and brushing needle |
EP1556120A4 (en) * | 2002-06-11 | 2011-03-09 | Cms Surgical Llc | System for efficient drainage of body cavity |
US7811274B2 (en) * | 2003-05-07 | 2010-10-12 | Portaero, Inc. | Method for treating chronic obstructive pulmonary disease |
US7426929B2 (en) | 2003-05-20 | 2008-09-23 | Portaero, Inc. | Intra/extra-thoracic collateral ventilation bypass system and method |
US7533667B2 (en) * | 2003-05-29 | 2009-05-19 | Portaero, Inc. | Methods and devices to assist pulmonary decompression |
US7252086B2 (en) * | 2003-06-03 | 2007-08-07 | Cordis Corporation | Lung reduction system |
US7682332B2 (en) * | 2003-07-15 | 2010-03-23 | Portaero, Inc. | Methods to accelerate wound healing in thoracic anastomosis applications |
JP2007512102A (en) | 2003-11-20 | 2007-05-17 | ザ ヘンリー エム. ジャクソン ファウンデーション フォー ザ アドヴァンスメント オブ ミリタリー メディシン, インク. | Portable manual pump for fluid suction |
US7306586B2 (en) * | 2003-12-30 | 2007-12-11 | Opmi Funding Corporation | Continuous drainage adaptor |
US7854731B2 (en) | 2004-03-18 | 2010-12-21 | C. R. Bard, Inc. | Valved catheter |
US7594911B2 (en) | 2004-03-18 | 2009-09-29 | C. R. Bard, Inc. | Connector system for a proximally trimmable catheter |
US7594910B2 (en) | 2004-03-18 | 2009-09-29 | C. R. Bard, Inc. | Catheter connector |
US8083728B2 (en) * | 2004-03-18 | 2011-12-27 | C. R. Bard, Inc. | Multifunction adaptor for an open-ended catheter |
US7578803B2 (en) * | 2004-03-18 | 2009-08-25 | C. R. Bard, Inc. | Multifunction adaptor for an open-ended catheter |
US7377915B2 (en) * | 2004-04-01 | 2008-05-27 | C. R. Bard, Inc. | Catheter connector system |
WO2005107843A1 (en) * | 2004-04-30 | 2005-11-17 | C.R. Bard, Inc. | Valved sheath introducer for venous cannulation |
US20050277827A1 (en) * | 2004-06-09 | 2005-12-15 | Alexandre Carvalho | Pleural fluid localization device and method of using |
US7670282B2 (en) * | 2004-06-14 | 2010-03-02 | Pneumrx, Inc. | Lung access device |
US20050281739A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue using compositions |
US20050281740A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Imaging damaged lung tissue |
US20050281799A1 (en) | 2004-06-16 | 2005-12-22 | Glen Gong | Targeting damaged lung tissue using compositions |
US7553810B2 (en) * | 2004-06-16 | 2009-06-30 | Pneumrx, Inc. | Lung volume reduction using glue composition |
US20060004400A1 (en) | 2004-06-16 | 2006-01-05 | Mcgurk Erin | Method of treating a lung |
US7678767B2 (en) | 2004-06-16 | 2010-03-16 | Pneumrx, Inc. | Glue compositions for lung volume reduction |
US7608579B2 (en) * | 2004-06-16 | 2009-10-27 | Pneumrx, Inc. | Lung volume reduction using glue compositions |
US20050281798A1 (en) * | 2004-06-16 | 2005-12-22 | Glen Gong | Targeting sites of damaged lung tissue using composition |
US7766938B2 (en) * | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Pleural effusion treatment device, method and material |
US7766891B2 (en) * | 2004-07-08 | 2010-08-03 | Pneumrx, Inc. | Lung device with sealing features |
US7387610B2 (en) * | 2004-08-19 | 2008-06-17 | Cardiac Pacemakers, Inc. | Thoracic impedance detection with blood resistivity compensation |
US8337475B2 (en) | 2004-10-12 | 2012-12-25 | C. R. Bard, Inc. | Corporeal drainage system |
US20060118126A1 (en) * | 2004-11-19 | 2006-06-08 | Don Tanaka | Methods and devices for controlling collateral ventilation |
US8220460B2 (en) * | 2004-11-19 | 2012-07-17 | Portaero, Inc. | Evacuation device and method for creating a localized pleurodesis |
CA2587857C (en) * | 2004-11-23 | 2017-10-10 | Pneumrx, Inc. | Steerable device for accessing a target site and methods |
US8403890B2 (en) | 2004-11-29 | 2013-03-26 | C. R. Bard, Inc. | Reduced friction catheter introducer and method of manufacturing and using the same |
US8926564B2 (en) | 2004-11-29 | 2015-01-06 | C. R. Bard, Inc. | Catheter introducer including a valve and valve actuator |
US8932260B2 (en) | 2004-11-29 | 2015-01-13 | C. R. Bard, Inc. | Reduced-friction catheter introducer and method of manufacturing and using the same |
US9597483B2 (en) | 2004-11-29 | 2017-03-21 | C. R. Bard, Inc. | Reduced-friction catheter introducer and method of manufacturing and using the same |
US7824366B2 (en) * | 2004-12-10 | 2010-11-02 | Portaero, Inc. | Collateral ventilation device with chest tube/evacuation features and method |
US7907997B2 (en) * | 2005-05-11 | 2011-03-15 | Cardiac Pacemakers, Inc. | Enhancements to the detection of pulmonary edema when using transthoracic impedance |
US7340296B2 (en) * | 2005-05-18 | 2008-03-04 | Cardiac Pacemakers, Inc. | Detection of pleural effusion using transthoracic impedance |
US7875019B2 (en) | 2005-06-20 | 2011-01-25 | C. R. Bard, Inc. | Connection system for multi-lumen catheter |
US8104474B2 (en) * | 2005-08-23 | 2012-01-31 | Portaero, Inc. | Collateral ventilation bypass system with retention features |
US20070078442A1 (en) * | 2005-08-24 | 2007-04-05 | Mayse Martin L | Tapered attachment for pleural catheter |
WO2007038643A1 (en) * | 2005-09-26 | 2007-04-05 | C.R. Bard, Inc. | Catheter connection systems |
US8888800B2 (en) | 2006-03-13 | 2014-11-18 | Pneumrx, Inc. | Lung volume reduction devices, methods, and systems |
US8157837B2 (en) | 2006-03-13 | 2012-04-17 | Pneumrx, Inc. | Minimally invasive lung volume reduction device and method |
US9402633B2 (en) | 2006-03-13 | 2016-08-02 | Pneumrx, Inc. | Torque alleviating intra-airway lung volume reduction compressive implant structures |
US20100297218A1 (en) * | 2006-09-20 | 2010-11-25 | Pneumrx, Inc. | Tissue adhesive compositions and methods thereof |
JP4994775B2 (en) | 2006-10-12 | 2012-08-08 | 日本コヴィディエン株式会社 | Needle point protector |
US7763033B2 (en) * | 2006-10-18 | 2010-07-27 | Interlace Medical, Inc. | System and methods for preventing intravasation during intrauterine procedures |
US9392935B2 (en) * | 2006-11-07 | 2016-07-19 | Hologic, Inc. | Methods for performing a medical procedure |
US8025656B2 (en) | 2006-11-07 | 2011-09-27 | Hologic, Inc. | Methods, systems and devices for performing gynecological procedures |
US8574253B2 (en) * | 2007-04-06 | 2013-11-05 | Hologic, Inc. | Method, system and device for tissue removal |
US9095366B2 (en) * | 2007-04-06 | 2015-08-04 | Hologic, Inc. | Tissue cutter with differential hardness |
US9259233B2 (en) | 2007-04-06 | 2016-02-16 | Hologic, Inc. | Method and device for distending a gynecological cavity |
US20090270895A1 (en) | 2007-04-06 | 2009-10-29 | Interlace Medical, Inc. | Low advance ratio, high reciprocation rate tissue removal device |
US8163034B2 (en) * | 2007-05-11 | 2012-04-24 | Portaero, Inc. | Methods and devices to create a chemically and/or mechanically localized pleurodesis |
US20080281151A1 (en) * | 2007-05-11 | 2008-11-13 | Portaero, Inc. | Pulmonary pleural stabilizer |
US7931641B2 (en) * | 2007-05-11 | 2011-04-26 | Portaero, Inc. | Visceral pleura ring connector |
US20080283065A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Methods and devices to maintain patency of a lumen in parenchymal tissue of the lung |
US20080287878A1 (en) * | 2007-05-15 | 2008-11-20 | Portaero, Inc. | Pulmonary visceral pleura anastomosis reinforcement |
US8062315B2 (en) | 2007-05-17 | 2011-11-22 | Portaero, Inc. | Variable parietal/visceral pleural coupling |
US20080295829A1 (en) * | 2007-05-30 | 2008-12-04 | Portaero, Inc. | Bridge element for lung implant |
CN101903062A (en) | 2007-10-19 | 2010-12-01 | C·R·巴德股份有限公司 | Introducer including shaped distal region |
ES2626630T3 (en) * | 2007-10-30 | 2017-07-25 | Uti Limited Partnership | Procedure and system of sustained release of sclerosing agent |
EP2242527A4 (en) * | 2008-02-19 | 2011-07-13 | Portaero Inc | Devices and methods for delivery of a therapeutic agent through a pneumostoma |
US8475389B2 (en) * | 2008-02-19 | 2013-07-02 | Portaero, Inc. | Methods and devices for assessment of pneumostoma function |
US8336540B2 (en) * | 2008-02-19 | 2012-12-25 | Portaero, Inc. | Pneumostoma management device and method for treatment of chronic obstructive pulmonary disease |
US10272178B2 (en) | 2008-04-29 | 2019-04-30 | Virginia Tech Intellectual Properties Inc. | Methods for blood-brain barrier disruption using electrical energy |
US8992517B2 (en) | 2008-04-29 | 2015-03-31 | Virginia Tech Intellectual Properties Inc. | Irreversible electroporation to treat aberrant cell masses |
US10245098B2 (en) | 2008-04-29 | 2019-04-02 | Virginia Tech Intellectual Properties, Inc. | Acute blood-brain barrier disruption using electrical energy based therapy |
US11272979B2 (en) | 2008-04-29 | 2022-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US10238447B2 (en) | 2008-04-29 | 2019-03-26 | Virginia Tech Intellectual Properties, Inc. | System and method for ablating a tissue site by electroporation with real-time monitoring of treatment progress |
AU2009243079A1 (en) | 2008-04-29 | 2009-11-05 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation to create tissue scaffolds |
US9198733B2 (en) | 2008-04-29 | 2015-12-01 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for electroporation-based therapies |
US11254926B2 (en) | 2008-04-29 | 2022-02-22 | Virginia Tech Intellectual Properties, Inc. | Devices and methods for high frequency electroporation |
US9283051B2 (en) | 2008-04-29 | 2016-03-15 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating a treatment volume for administering electrical-energy based therapies |
US10117707B2 (en) | 2008-04-29 | 2018-11-06 | Virginia Tech Intellectual Properties, Inc. | System and method for estimating tissue heating of a target ablation zone for electrical-energy based therapies |
US9867652B2 (en) | 2008-04-29 | 2018-01-16 | Virginia Tech Intellectual Properties, Inc. | Irreversible electroporation using tissue vasculature to treat aberrant cell masses or create tissue scaffolds |
US10702326B2 (en) | 2011-07-15 | 2020-07-07 | Virginia Tech Intellectual Properties, Inc. | Device and method for electroporation based treatment of stenosis of a tubular body part |
US9173669B2 (en) | 2008-09-12 | 2015-11-03 | Pneumrx, Inc. | Enhanced efficacy lung volume reduction devices, methods, and systems |
US8347881B2 (en) * | 2009-01-08 | 2013-01-08 | Portaero, Inc. | Pneumostoma management device with integrated patency sensor and method |
US8518053B2 (en) * | 2009-02-11 | 2013-08-27 | Portaero, Inc. | Surgical instruments for creating a pneumostoma and treating chronic obstructive pulmonary disease |
US11382681B2 (en) | 2009-04-09 | 2022-07-12 | Virginia Tech Intellectual Properties, Inc. | Device and methods for delivery of high frequency electrical pulses for non-thermal ablation |
US11638603B2 (en) | 2009-04-09 | 2023-05-02 | Virginia Tech Intellectual Properties, Inc. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US11903602B2 (en) | 2009-04-29 | 2024-02-20 | Hologic, Inc. | Uterine fibroid tissue removal device |
CN102573700B (en) * | 2009-05-18 | 2014-12-17 | 纽姆克斯股份有限公司 | Cross-sectional modification during deployment of an elongate lung volume reduction device |
WO2010138919A2 (en) | 2009-05-28 | 2010-12-02 | Angiodynamics, Inc. | System and method for synchronizing energy delivery to the cardiac rhythm |
US9895189B2 (en) | 2009-06-19 | 2018-02-20 | Angiodynamics, Inc. | Methods of sterilization and treating infection using irreversible electroporation |
WO2010151825A1 (en) | 2009-06-26 | 2010-12-29 | C. R. Bard, Inc. | Proximally trimmable catheter including pre-attached bifurcation and related methods |
US8784394B2 (en) * | 2009-07-22 | 2014-07-22 | Marshall Kerr | Method and apparatus for treatment of pleural effusion |
US8425455B2 (en) | 2010-03-30 | 2013-04-23 | Angiodynamics, Inc. | Bronchial catheter and method of use |
RU2577761C2 (en) | 2010-05-07 | 2016-03-20 | Кеафьюжин 2200, Инк. | Improved method of treating pleural effusion |
EP3578205A1 (en) | 2010-08-06 | 2019-12-11 | ModernaTX, Inc. | A pharmaceutical formulation comprising engineered nucleic acids and medical use thereof |
CA2813466A1 (en) | 2010-10-01 | 2012-04-05 | Moderna Therapeutics, Inc. | Modified nucleosides, nucleotides, and nucleic acids that disrupt major groove binding partner interactions |
WO2012051433A2 (en) | 2010-10-13 | 2012-04-19 | Angiodynamics, Inc. | System and method for electrically ablating tissue of a patient |
US20120101471A1 (en) * | 2010-10-22 | 2012-04-26 | Di Palma Giorgio | Self-powered infusion device and method of use |
WO2012088149A2 (en) | 2010-12-20 | 2012-06-28 | Virginia Tech Intellectual Properties, Inc. | High-frequency electroporation for cancer therapy |
CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
US8486024B2 (en) | 2011-04-27 | 2013-07-16 | Covidien Lp | Safety IV catheter assemblies |
US20120298114A1 (en) | 2011-05-26 | 2012-11-29 | Carefusion 2200, Inc. | Wound dressing system |
US20120302950A1 (en) | 2011-05-26 | 2012-11-29 | Carefusion 2200, Inc. | Active pleurodesis catheter |
US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
WO2013048975A1 (en) | 2011-09-26 | 2013-04-04 | Covidien Lp | Safety catheter |
US8715250B2 (en) | 2011-09-26 | 2014-05-06 | Covidien Lp | Safety catheter and needle assembly |
US9078665B2 (en) | 2011-09-28 | 2015-07-14 | Angiodynamics, Inc. | Multiple treatment zone ablation probe |
CN110511939A (en) | 2011-10-03 | 2019-11-29 | 现代泰克斯公司 | Nucleosides, nucleotide and nucleic acid of modification and application thereof |
US8834422B2 (en) | 2011-10-14 | 2014-09-16 | Covidien Lp | Vascular access assembly and safety device |
US20130102999A1 (en) | 2011-10-25 | 2013-04-25 | Anthony M. Looper | Pleurodesis catheter with coated and shielded tip |
EP2791160B1 (en) | 2011-12-16 | 2022-03-02 | ModernaTX, Inc. | Modified mrna compositions |
US20130226114A1 (en) | 2012-02-29 | 2013-08-29 | Shayna Massi | Drainage system |
EP2833923A4 (en) | 2012-04-02 | 2016-02-24 | Moderna Therapeutics Inc | Modified polynucleotides for the production of proteins |
US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
US9878056B2 (en) | 2012-04-02 | 2018-01-30 | Modernatx, Inc. | Modified polynucleotides for the production of cosmetic proteins and peptides |
PT2922554T (en) | 2012-11-26 | 2022-06-28 | Modernatx Inc | Terminally modified rna |
US9888956B2 (en) | 2013-01-22 | 2018-02-13 | Angiodynamics, Inc. | Integrated pump and generator device and method of use |
US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
SG11201602503TA (en) | 2013-10-03 | 2016-04-28 | Moderna Therapeutics Inc | Polynucleotides encoding low density lipoprotein receptor |
US9682218B2 (en) | 2013-12-23 | 2017-06-20 | Carefusion 2200, Inc. | Pleurodesis device and method |
AU2015259303B2 (en) | 2014-05-12 | 2021-10-28 | Arena, Christopher B. | Selective modulation of intracellular effects of cells using pulsed electric fields |
US10390838B1 (en) | 2014-08-20 | 2019-08-27 | Pneumrx, Inc. | Tuned strength chronic obstructive pulmonary disease treatment |
SG10201406976SA (en) * | 2014-10-27 | 2016-05-30 | Aci Medical Pte Ltd | Intravenous catheter assembly |
EP3215211A4 (en) | 2014-11-07 | 2018-07-04 | C. R. Bard, Inc. | Connection system for tunneled catheters |
WO2016100325A1 (en) | 2014-12-15 | 2016-06-23 | Virginia Tech Intellectual Properties, Inc. | Devices, systems, and methods for real-time monitoring of electrophysical effects during tissue treatment |
US10610665B2 (en) * | 2016-05-31 | 2020-04-07 | Carefusion 2200, Inc. | Body cavity drainage catheter with microtextured surface |
US10702281B2 (en) | 2016-07-18 | 2020-07-07 | Merit Medical Systems, Inc. | Inflatable radial artery compression device |
US11282602B2 (en) | 2016-10-26 | 2022-03-22 | Carefusion 2200, Inc. | Device and method for mobile monitoring of drainage catheter |
US10905815B2 (en) | 2016-10-26 | 2021-02-02 | Carefusion 2200, Inc. | Multi-lumen indwelling catheter |
US10905492B2 (en) | 2016-11-17 | 2021-02-02 | Angiodynamics, Inc. | Techniques for irreversible electroporation using a single-pole tine-style internal device communicating with an external surface electrode |
US11007359B2 (en) * | 2017-02-16 | 2021-05-18 | Canadian Hospital Specialties Limited | Connector for catheter |
EP3609562A1 (en) * | 2017-04-14 | 2020-02-19 | Access Scientific, LLC | Vascular access device |
US11185617B2 (en) | 2017-07-31 | 2021-11-30 | Becton, Dickinson And Company | Drainage system with retention ring |
WO2019040801A1 (en) | 2017-08-23 | 2019-02-28 | C.R. Bard, Inc. | Catheter assemblies and methods thereof |
US11607537B2 (en) | 2017-12-05 | 2023-03-21 | Virginia Tech Intellectual Properties, Inc. | Method for treating neurological disorders, including tumors, with electroporation |
US11311329B2 (en) | 2018-03-13 | 2022-04-26 | Virginia Tech Intellectual Properties, Inc. | Treatment planning for immunotherapy based treatments using non-thermal ablation techniques |
US11925405B2 (en) | 2018-03-13 | 2024-03-12 | Virginia Tech Intellectual Properties, Inc. | Treatment planning system for immunotherapy enhancement via non-thermal ablation |
AU2019268330A1 (en) | 2018-05-15 | 2020-11-26 | Voyager Therapeutics, Inc. | Compositions and methods for the treatment of Parkinson's disease |
US11950835B2 (en) | 2019-06-28 | 2024-04-09 | Virginia Tech Intellectual Properties, Inc. | Cycled pulsing to mitigate thermal damage for multi-electrode irreversible electroporation therapy |
US20210205523A1 (en) * | 2020-01-03 | 2021-07-08 | Stanley Batiste | Catheter Clearance Device and Method of Use |
US11577065B1 (en) | 2022-04-29 | 2023-02-14 | Pleural Dynamics, Inc. | Fluid-management system and method |
US11707614B1 (en) | 2022-04-29 | 2023-07-25 | Pleural Dynamics, Inc. | Fluid-management system and method |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4669463A (en) * | 1984-02-22 | 1987-06-02 | Mcconnell Richard B | Endotracheal tube injection site addition |
US4874377A (en) * | 1988-05-26 | 1989-10-17 | Davis Newgard Revocable Family Living Trust | Self-occluding intravascular cannula assembly |
US4960412A (en) * | 1988-04-15 | 1990-10-02 | Universal Medical Instrument Corp. | Catheter introducing system |
US4973311A (en) * | 1986-12-27 | 1990-11-27 | Kabushiki Kaisha Toshiba | Aspirator for endoscopic system |
US5009636A (en) * | 1989-12-06 | 1991-04-23 | The Kendall Company | Dual-lumen catheter apparatus and method |
US5057084A (en) * | 1990-03-01 | 1991-10-15 | The Regents Of The University Of Michigan | Implantable infusion device |
US5061255A (en) * | 1985-10-15 | 1991-10-29 | Albert Greenfeld | Exterior antimigration refinements for self-cleaning indwelling therapeutic articles |
US5141499A (en) * | 1991-10-09 | 1992-08-25 | Zappacosta Anthony R | Peritoneal dialysis catheter |
US5156597A (en) * | 1989-12-30 | 1992-10-20 | B. Braun Melsungen Ag | Transcutaneous implantation catheter |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4929235A (en) * | 1985-07-31 | 1990-05-29 | Universal Medical Instrument Corp. | Self-sealing percutaneous tube introducer |
US4946449A (en) * | 1986-12-18 | 1990-08-07 | Davis Jr Richard C | Indwelling urethral catheter system and method |
US5064416A (en) * | 1988-05-26 | 1991-11-12 | Newgard Kent W | Self-occluding intravascular cannula assembly |
US4944732A (en) * | 1988-08-15 | 1990-07-31 | Sandoz Nutrition Corporation | Gastrostomy feeding port |
US5106054A (en) * | 1990-08-23 | 1992-04-21 | Thomas J. Fogarty | Self-sealing hemostasis valve apparatus and method of forming the same |
US5098405A (en) * | 1991-01-31 | 1992-03-24 | Becton, Dickinson And Company | Apparatus and method for a side port cathether adapter with a one piece integral combination valve |
US5207655A (en) * | 1991-05-15 | 1993-05-04 | Sheridan Catheter Corp. | Medico-surgical tube including improved means for administering liquid or gas treatment |
-
1993
- 1993-11-03 WO PCT/US1993/010530 patent/WO1994009838A1/en active Application Filing
- 1993-11-03 AU AU56656/94A patent/AU5665694A/en not_active Abandoned
-
1994
- 1994-05-31 US US08/251,692 patent/US5484401A/en not_active Expired - Lifetime
Patent Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4669463A (en) * | 1984-02-22 | 1987-06-02 | Mcconnell Richard B | Endotracheal tube injection site addition |
US5061255A (en) * | 1985-10-15 | 1991-10-29 | Albert Greenfeld | Exterior antimigration refinements for self-cleaning indwelling therapeutic articles |
US4973311A (en) * | 1986-12-27 | 1990-11-27 | Kabushiki Kaisha Toshiba | Aspirator for endoscopic system |
US4960412A (en) * | 1988-04-15 | 1990-10-02 | Universal Medical Instrument Corp. | Catheter introducing system |
US4874377A (en) * | 1988-05-26 | 1989-10-17 | Davis Newgard Revocable Family Living Trust | Self-occluding intravascular cannula assembly |
US5009636A (en) * | 1989-12-06 | 1991-04-23 | The Kendall Company | Dual-lumen catheter apparatus and method |
US5156597A (en) * | 1989-12-30 | 1992-10-20 | B. Braun Melsungen Ag | Transcutaneous implantation catheter |
US5057084A (en) * | 1990-03-01 | 1991-10-15 | The Regents Of The University Of Michigan | Implantable infusion device |
US5141499A (en) * | 1991-10-09 | 1992-08-25 | Zappacosta Anthony R | Peritoneal dialysis catheter |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014152712A1 (en) * | 2013-03-15 | 2014-09-25 | Merit Medical Systems, Inc. | Lockable syringe assemblies and related devices and methods |
US9561327B2 (en) | 2013-03-15 | 2017-02-07 | Merit Medical Systems, Inc. | Lockable syringe assemblies and related devices and methods |
US11350945B2 (en) | 2017-11-13 | 2022-06-07 | Merit Medical Systems, Inc. | Staged deflation syringe systems and associated methods |
Also Published As
Publication number | Publication date |
---|---|
US5484401A (en) | 1996-01-16 |
AU5665694A (en) | 1994-05-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US5484401A (en) | Treatment method for pleural effusion | |
US5620424A (en) | Device for preventing catheter related infection | |
US5279551A (en) | Trocar catheter | |
US5318517A (en) | Multiple lumen thoracostomy catheter and method for administering anesthesia | |
US5078688A (en) | Paracentesis catheter system | |
US4800901A (en) | Balloon-type Tissue expansion device | |
US6132415A (en) | Systems and methods for removing retained fluids and infusing therapeutic fluids | |
US4488877A (en) | Percutaneous implant for peritoneal dialysis | |
US5209723A (en) | Multiple lumen catheter for hemodialysis | |
US4936826A (en) | Vena cava window | |
ES2706975T3 (en) | Septum of intravenous catheter set for multiple use and septum actuator | |
US5360397A (en) | Hemodiaylsis catheter and catheter assembly | |
EP2079409B1 (en) | Vascular access device gas displacement | |
US7094218B2 (en) | Valved catheter | |
ES2425233T3 (en) | Vascular access device chamber ventilation | |
US20200030592A1 (en) | Apparatus For Administering Liquids To A Human Intravenously Via An Implanted Port | |
MXPA03010227A (en) | Combined needle and dilator device for central venous and arterial catheterization. | |
EP3706854A2 (en) | Modular valved connector for drainage systems | |
CN111330137A (en) | Drug delivery device | |
CN209771078U (en) | drug delivery device | |
US11007359B2 (en) | Connector for catheter | |
ES2802907T3 (en) | Pleurodesis device | |
US20140207116A1 (en) | Implantable High Flow Dual Lumen Multi-Window Vascular Access Port Catheter | |
KR20200111026A (en) | Catheter device for reducing the pain after surgery | |
US20060264899A1 (en) | Transcutaneous fluid drain kit |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |